—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Medpace Holdings Inc (MEDP) — Technical state

As of 2026-11-02 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 62 out of 100 (momentum 88 · quality 75 · valuation 25), as of 2026-11-03.
  • Signal: Uptrend stack intact — Trades +4.6% vs the 50-day and +22.4% vs the 200-day average, 6.6% below the 52-week high and +73.8% off the 52-week low; a golden cross printed 61 sessions ago. Computed from daily closes. (as of 2026-11-02)
  • Trend: Medpace Holdings Inc trades 4.6% above its 50-day and 22.4% above its 200-day moving average. (as of 2026-11-02)

Medpace runs clinical trials on behalf of drug and device makers, covering everything from early human-safety studies through to post-marketing follow-up. It designs trial protocols, manages regulatory filings, monitors sites, and analyses the resulting data across many disease areas.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the MEDP overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Uptrend stack intact

Trades +4.6% vs the 50-day and +22.4% vs the 200-day average, 6.6% below the 52-week high and +73.8% off the 52-week low; a golden cross printed 61 sessions ago. Computed from daily closes.

The moving-average stack

Continue: the MEDP chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-02

Quick answers

What is the current Closelooknet signal on MEDP?

Uptrend stack intact — Trades +4.6% vs the 50-day and +22.4% vs the 200-day average, 6.6% below the 52-week high and +73.8% off the 52-week low; a golden cross printed 61 sessions ago. Computed from daily closes. As of 2026-11-02; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is MEDP above its 50-day and 200-day moving averages?

As of 2026-11-02, Medpace Holdings Inc trades +4.6% above its 50-day and +22.4% above its 200-day average, with the 20-day +1.6% away.

How far is MEDP from its 52-week high?

6.6% below the 52-week high and 73.8% above the 52-week low, as of 2026-11-02.

Related in the Closelooknet universe

then Diagnostics & Research. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.